Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 11, 2015 - Issue 1: Special Focus: 10-year anniversary issue
Submit an article Journal homepage
384
Views
14
CrossRef citations to date
0
Altmetric
SPECIAL FOCUS: 10-year anniversary issue - Review

Clinical management of multiple sclerosis and neuromyelitis optica with therapeutic monoclonal antibodies: approved therapies and emerging candidates

Divyanshu DubeyUT Southwestern, Dallas, TX, USA
,
Bernd C KieseierHeinrich-Heine University, Düsseldorf, Germany
,
Hans Peter HartungHeinrich-Heine-University Medical School, Düsseldorf, Germany
,
Bernhard HemmerTechnical University Munich, Munich, Germany
,
William A Miller-LittleUT Southwestern, Dallas, TX, USA
&
Olaf StuveVA North Texas Health Care System, Bonham, TX 75418, USACorrespondence[email protected]
Pages 93-108 | Published online: 15 Dec 2014

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Jennifer R. Evan, Subutay B. Bozkurt, Nikita C. Thomas & Francesca Bagnato. (2018) Alemtuzumab for the treatment of multiple sclerosis. Expert Opinion on Biological Therapy 18:3, pages 323-334.
Read now
Divyanshu Dubey, Kyle Blackburn, Benjamin Greenberg, Olaf Stuve & Steven Vernino. (2016) Diagnostic and therapeutic strategies for management of autoimmune encephalopathies. Expert Review of Neurotherapeutics 16:8, pages 937-949.
Read now
Divyanshu Dubey, Christopher A Cano & Olaf Stuve. (2015) Intractable and highly active relapsing multiple sclerosis – role of alemtuzumab. Neuropsychiatric Disease and Treatment 11, pages 2405-2414.
Read now
Thomas G Forsthuber & Timothy RDJ Radstake. (2015) Expert Review of Clinical Immunology 10-year anniversary issue. Expert Review of Clinical Immunology 11:1, pages 1-3.
Read now

Articles from other publishers (10)

Zeinab Jan, Samaneh Mollazadeh, Khalil Abnous, Seyed Mohammad Taghdisi, Abolghasem Danesh, Mohammad Ramezani & Mona Alibolandi. (2022) Targeted Delivery Platforms for the Treatment of Multiple Sclerosis. Molecular Pharmaceutics 19:7, pages 1952-1976.
Crossref
Luisa Bell, Tobias Koeniger, Sabine Tacke & Stefanie Kuerten. (2019) Characterization of blood–brain barrier integrity in a B-cell-dependent mouse model of multiple sclerosis. Histochemistry and Cell Biology 151:6, pages 489-499.
Crossref
Austin Negron, Rachel R. Robinson, Olaf Stüve & Thomas G. Forsthuber. (2019) The role of B cells in multiple sclerosis: Current and future therapies. Cellular Immunology 339, pages 10-23.
Crossref
Divyanshu DubeyThomas ForsthuberEoin P. FlanaganSean J. PittockOlaf Stüve. (2017) B-cell–targeted therapies in relapsing forms of MS. Neurology Neuroimmunology & Neuroinflammation 4:6.
Crossref
Daniel Whittam, Martin Wilson, Shahd Hamid, Geoff Keir, Maneesh Bhojak & Anu Jacob. (2017) What’s new in neuromyelitis optica? A short review for the clinical neurologist. Journal of Neurology 264:11, pages 2330-2344.
Crossref
Ai-Lan Nguyen, Melissa Gresle, Tessa Marshall, Helmut Butzkueven & Judith Field. (2017) Monoclonal antibodies in the treatment of multiple sclerosis: emergence of B-cell-targeted therapies. British Journal of Pharmacology 174:13, pages 1895-1907.
Crossref
Takayuki Kondo, Misato Funayama, Michiyo Miyake, Kayoko Tsukita, Takumi Era, Hitoshi Osaka, Takashi Ayaki, Ryosuke Takahashi & Haruhisa Inoue. (2016) Modeling Alexander disease with patient iPSCs reveals cellular and molecular pathology of astrocytes. Acta Neuropathologica Communications 4:1.
Crossref
Divyanshu Dubey, Christopher A. Cano & Olaf Stüve. (2016) Update on monitoring and adverse effects of approved second-generation disease-modifying therapies in relapsing forms of multiple sclerosis. Current Opinion in Neurology 29:3, pages 278-285.
Crossref
Stefan Bittner & Heinz Wiendl. (2015) Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications. Neurotherapeutics 13:1, pages 4-19.
Crossref
Yasser El Miedany. (2015) MABS: targeted therapy tailored to the patient's need. British Journal of Nursing 24:Sup16a, pages S4-S13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.